ArticleInvestigative and clinical urology2022

Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder.

Hye Won Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.